In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Timothy A. Pratt net worth and biography

Timothy Pratt Biography and Net Worth

EVP of Boston Scientific

Tim has had a multifaceted and storied career. For many years, Tim was a national trial lawyer with the firm of Shook, Hardy and Bacon. He handled mass tort cases for pharmaceutical, medical device and chemical companies. Tim was lead counsel in a number of high-profile trials for clients around the country and served as lead counsel in a medical device MDL. While in private practice, he was named a Leading National Products Liability Lawyer by Chambers USA, one of the Top 500 Litigators in America by Lawdragon, and one of the Best Lawyers in America. Tim taught at the National Institute for Trial Advocacy for many years and was a frequent speaker on legal topics, trial tactics and litigation strategy.

In 2008, Tim was recruited to become General Counsel and Corporate Secretary of Boston Scientific, a multinational medical device company. While there, Tim served on the Company's Executive Committee and was responsible for worldwide management of the company's Legal organization, Global Compliance, Government Affairs, Aviation, Global Security and other functions. He was also heavily involved in diversity and inclusion initiatives, the Boston Scientific Leadership Academy and innovative outside counsel management initiatives. Over his years at Boston Scientific, Tim was repeatedly awarded for his performance. In 2013, he was recognized by The Legal 500 and named to the "Corporate Counsel 100" list, which identifies the top most powerful corporate legal advisers in the United States. In 2016 he was honored by The Burton Awards as a “Legend in Law.” In 2016, he was flattered to receive the Valued Ally Award from Diversity Best Practices for his work in advancing diversity and inclusion.

Tim's work and influence is not limited to his work at Shook, Hardy and Boston Scientific. He has also worked with a number of organizations. Tim was on the Board and Executive Committee of AdvaMed, the trade association for the medical device industry. He is active in the prestigious and invitation-only Federation of Defense & Corporate Counsel (FDCC), where he served as President and Chairman. He currently serves as President of Lawyers for Civil Justice (LCJ), a group interested in improving the civil justice system in the United States. He had been a member of the boards for DRI and the New England Legal Foundation.

What is Timothy A. Pratt's net worth?: The estimated net worth of Timothy A. Pratt is at least $13.92 million as of December 1st, 2017. Mr. Pratt owns 154,681 shares of Boston Scientific stock worth more than $13,921,290 as of November 23rd. This net worth evaluation does not reflect any other investments that Mr. Pratt may own. Learn More about Timothy A. Pratt's net worth.
How do I contact Timothy A. Pratt?: The corporate mailing address for Mr. Pratt and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]. Learn More on Timothy A. Pratt's contact information.
Has Timothy A. Pratt been buying or selling shares of Boston Scientific?: Timothy A. Pratt has not been actively trading shares of Boston Scientific during the last quarter. Most recently, Timothy A. Pratt sold 10,000 shares of the business's stock in a transaction on Friday, December 1st. The shares were sold at an average price of $26.04, for a transaction totalling $260,400.00. Following the completion of the sale, the executive vice president now directly owns 154,681 shares of the company's stock, valued at $4,027,893.24. Learn More on Timothy A. Pratt's trading history.
Who are Boston Scientific's active insiders?: Boston Scientific's insider roster includes Kevin Ballinger (EVP), Supratim Bose (EVP), Daniel Brennan (CFO), Vance Brown (SVP), Arthur Butcher (EVP), Wendy Carruthers (SVP), Nelda Connors (Director), Keith Dawkins (EVP), Charles Dockendorff (Director), Jodi Eddy (SVP), Joseph Fitzgerald (EVP), Edward Ludwig (Director), Edward Ludwig (Director), Edward Mackey (EVP), Michael Mahoney (CEO), Ian Meredith (EVP), Jeffrey Mirviss (EVP), Jonathan Monson (CAO), Maulik Nanavaty (SVP), Scott Olson (SVP), Michael Phalen (EVP), David Pierce (EVP), Timothy Pratt (EVP), Desiree Ralls-Morrison (SVP), Meghan Scanlon (SVP), John Sorenson (SVP), Eric Thepaut (EVP), Xin Wang (SVP), and David Wichmann (Director). Learn More on Boston Scientific's active insiders.
Are insiders buying or selling shares of Boston Scientific?: During the last twelve months, insiders at the medical equipment provider sold shares 22 times. They sold a total of 486,553 shares worth more than $38,417,686.88. The most recent insider tranaction occured on November, 21st when Director Edward J Ludwig sold 4,877 shares worth more than $446,879.51. Insiders at Boston Scientific own 0.5% of the company. Learn More about insider trades at Boston Scientific.
Information on this page was last updated on 11/21/2024.

Timothy A. Pratt Insider Trading History at Boston Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2017	Sell	10,000	$26.04	$260,400.00	154,681
11/1/2017	Sell	10,000	$28.22	$282,200.00	164,681
10/2/2017	Sell	11,061	$29.24	$323,423.64	174,681
9/1/2017	Sell	10,104	$27.46	$277,455.84	185,742
8/1/2017	Sell	10,000	$26.67	$266,700.00	195,846
7/3/2017	Sell	10,000	$27.87	$278,700.00	205,846
6/1/2017	Sell	10,000	$27.13	$271,300.00	215,846
5/1/2017	Sell	10,000	$26.37	$263,700.00	225,846
4/3/2017	Sell	10,000	$24.87	$248,700.00	235,846
3/3/2017	Sell	23,540	$25.01	$588,735.40	245,846
2/27/2017	Sell	4,832	$24.84	$120,026.88	248,758
1/9/2017	Sell	6,195	$22.24	$137,776.80	231,273
12/1/2016	Sell	26,726	$20.48	$547,348.48	260,430
8/1/2016	Sell	24,000	$24.46	$587,040.00	287,495
6/1/2016	Sell	24,229	$22.66	$549,029.14	301,724
5/2/2016	Sell	24,000	$21.93	$526,320.00	308,724
4/27/2016	Sell	39,927	$21.40	$854,437.80	291,724
4/1/2016	Sell	24,000	$18.73	$449,520.00	355,651
3/1/2016	Sell	15,068	$16.97	$255,703.96	338,651
1/8/2016	Sell	7,160	$17.67	$126,517.20	303,776
12/1/2015	Sell	24,000	$18.43	$442,320.00	282,295
11/5/2015	Sell	19,598	$19.00	$372,362.00	289,295
10/28/2015	Sell	3,500	$18.00	$63,000.00	315,893
10/5/2015	Sell	3,500	$17.34	$60,690.00	319,393
10/1/2015	Sell	17,000	$16.33	$277,610.00	322,893

Timothy A. Pratt Buying and Selling Activity at Boston Scientific

Boston Scientific Company Overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $90.00

$89.02

$91.93

50 Day Range

MA: $85.99

$82.52

$91.54

2 Week Range

Now: $90.00

$53.93

$91.93

Volume

5,571,738 shs

Average Volume

6,442,305 shs

Market Capitalization

$132.64 billion

P/E Ratio

74.38

Dividend Yield

N/A

Beta

0.79

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad